{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T23:19:11Z","timestamp":1648595951679},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1999,12,1]],"date-time":"1999-12-01T00:00:00Z","timestamp":944006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[1999,12]]},"DOI":"10.1007\/s11906-996-0026-7","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T20:17:21Z","timestamp":1180124241000},"page":"529-539","source":"Crossref","is-referenced-by-count":3,"title":["Hypertension in pregnancy: New recommendations for managemen"],"prefix":"10.1007","volume":"1","author":[{"given":"Roberta","family":"Shear","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Line","family":"Leduc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelyne","family":"Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie","family":"Moutquin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"26_CR1","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/0002-9378(90)90652-N","volume":"163","author":"National High Blood Pressure Education Program","year":"1990","unstructured":"National High Blood Pressure Education Program: Working group on high blood pressure in pregnancy. Am J Obstet Gynecol 1990, 163:1689\u20131712.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-2007-994387","volume":"12","author":"K Harm","year":"1995","unstructured":"Harm K, Rath W, Hertig E, et al.: Maternal hemolysis, elevated liver enzymes, low platelets count and neonatal income. Am J Perinatol 1995, 12:1\u20136.","journal-title":"Am J Perinatol"},{"key":"26_CR3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0002-9378(94)90276-3","volume":"171","author":"E Rey","year":"1994","unstructured":"Rey E, Couturier A: The prognosis of women with chronic hypertension. Am J Obstet Gynecol 1994, 171:410\u2013416.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR4","first-page":"715","volume":"157","author":"ME Helewa","year":"1997","unstructured":"Helewa ME, Burrows RF, Smith J, et al.: Report of the Canadian Hypertension Society Consensus Conference: definition, evaluation and classification of hypertensive disorders in pregnancy. Can Med Assoc J 1997, 157:715\u2013725.","journal-title":"Can Med Assoc J"},{"key":"26_CR5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0002-9378(85)90010-9","volume":"151","author":"JM Moutquin","year":"1985","unstructured":"Moutquin JM, Rainville C, Giroux L, et al.: A prospective study of blood pressure in pregnancy: prediction of preeclampsia. Am J Obstet Gynecol 1985, 151:191\u2013196.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR6","first-page":"1366","volume":"175","author":"RB Ness","year":"1996","unstructured":"Ness RB, Roberts JM: Heterogenous causes constituting the single syndrome of preeclamsia: a hypothesis and its implications. Am J Obstet Gynecol 1996, 175:1366\u20131370.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0002-9378(93)90608-L","volume":"169","author":"J Mass\u00e9","year":"1993","unstructured":"Mass\u00e9 J, Forest JC, Moutquin JM, et al.: A prospective study of several potential markers for early detection of development of preeclampsia. Am J Obstet Gynecol 1993, 169:501\u2013508.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0029-7844(97)00702-3","volume":"91","author":"L Pouliot","year":"1998","unstructured":"Pouliot L, Forest JC, Moutquin JM, et al.: Platelet angiotensin II binding sites and early detection of preeclampsia. Obstet Gynecol 1998, 91:591\u2013595.","journal-title":"Obstet Gynecol"},{"key":"26_CR9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0002-9378(95)90112-4","volume":"172","author":"MJ Endresen","year":"1995","unstructured":"Endresen MJ, Tosti E, Lorentzen B, et al.: Sera of preeclampsia women are not cytotoxic to endothelial cells in culture. Am J Obstet Gynecol 1995, 172:196\u2013100.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR10","first-page":"445","volume":"75","author":"TF O\u2019Brien","year":"1990","unstructured":"O\u2019Brien TF: Predicting preeclampsia. Obstet Gynecol 1990, 75:445\u2013452.","journal-title":"Obstet Gynecol"},{"key":"26_CR11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1471-0528.1998.tb10128.x","volume":"105","author":"O Irion","year":"1998","unstructured":"Irion O, Mass\u00e9 J, Forest JC, et al.: Prediction of preeclampsia, low birthweight for gestation and prematurity by uterine artery blood flow velocity waveforms analysis in low risk nulliparas. Br J Obstet Gynaecol 1998, 105:422\u2013429.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR12","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1471-0528.1986.tb08006.x","volume":"93","author":"LC Chesley","year":"1986","unstructured":"Chesley LC, Cooper DW: Genetics of hypertension in pregnancy: possible single gene control of preeclampsia and eclampsia in the descendants of eclamptic women. Br J Obstet Gynaecol 1986, 93:898\u2013906.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1471-0528.1988.tb06524.x","volume":"95","author":"DW Cooper","year":"1988","unstructured":"Cooper DW, Hill JA, Chesley LC, et al.: Genetic control of susceptibility to eclampsia and miscarriage. Br J Obstet Gynaecol 1988, 95:644\u2013653.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1471-0528.1999.tb08326.x","volume":"106","author":"JG Thornton","year":"1999","unstructured":"Thornton JG, Macdonald AM: Twin mothers pregnancy hypertension and preeclampsia. Br J Obstet Gynaecol 1999, 106:570\u2013575.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ng0593-59","volume":"4","author":"K Ward","year":"1993","unstructured":"Ward K, Hata A, Jeunemaitre X, et al.: A molecular variant of antiogensinogen associated with preeclampsia. Nature Genetics 1993, 4:59\u201361.","journal-title":"Nature Genetics"},{"key":"26_CR16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0693-114","volume":"4","author":"R Arngrimson","year":"1993","unstructured":"Arngrimson R, Purandare S, Connor M, et al.: Angiotnesinogen: a candidate gene involved in preeclampsia? Nature Genetics 1993, 4:114\u2013115.","journal-title":"Nature Genetics"},{"key":"26_CR17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/10641959509009586","volume":"14","author":"AN Wilton","year":"1995","unstructured":"Wilton AN, Kaye JA, Guo G, et al.: Is angiotensinogen a good candidate gene for preeclampsia ? Hypertens Preg 1995, 14:251\u2013260.","journal-title":"Hypertens Preg"},{"key":"26_CR18","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/S0002-9378(96)70619-1","volume":"174","author":"T Folgero","year":"1996","unstructured":"Folgero T, Storbakk N, Torbergsen T, et al.: Mutations in mitochondrial transfert ribonucleic acid genes in preeclampsia. Am J Obstet Gynecol 1996, 174:1626\u20131630.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1471-0528.1995.tb11427.x","volume":"102","author":"KE Humphrey","year":"1995","unstructured":"Humphrey KE, Jarrison GA, Cooper DW, et al.: HLA-G deletion polymorphism and preeclamsia\/eclampsia. Br J Obstet Gynaecol 1995, 102:707\u2013710.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/00016349409013385","volume":"73","author":"R Arngrimsson","year":"1994","unstructured":"Arngrimsson R, Geirsson RT, Cooke A, et al.: Renin gene restrictions fragment length polymorphisms do not show linkage with preeclampsia and eclampsia. Acta Obstet Gynecol Scand 1994, 73:10\u201313.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"26_CR21","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/0002-9378(95)90625-8","volume":"173","author":"E Schiff","year":"1995","unstructured":"Schiff E, Friedman SA, Sibai BM, et al.: Plasma and placental calcitonin gene-related peptide in pregnancies complicated by severe preeclampsia. Am J Obstet Gynecol 1995, 173:1405\u2013409.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00004872-199715120-00004","volume":"15","author":"L Morgan","year":"1997","unstructured":"Morgan L, Crawshaw S, Bajer PN, et al.: Function and genetic studies of the angiotensin II type 1 receptor in preeclampsia and normotensive pregnant woment. J Hypertens 1997, 15:1389\u20131396.","journal-title":"J Hypertens"},{"key":"26_CR23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2249.1996.d01-647.x","volume":"104","author":"G Chen","year":"1996","unstructured":"Chen G, Wilson R, Wang SH, et al.: Tumor necrosis factor-alpha (TNF-alpha) gene polymorphism and expression in preeclampsia. Clin Exp Immunol 1996, 104:154\u2013159.","journal-title":"Clin Exp Immunol"},{"key":"26_CR24","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/0002-9378(95)91324-6","volume":"173","author":"GA Dekker","year":"1995","unstructured":"Dekker GA, de Vries JIP, Doelitzsch PM, et al.: Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995, 173:1042\u20131048.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/(SICI)1520-6661(199811\/12)7:6<277::AID-MFM5>3.0.CO;2-3","volume":"7","author":"F Arias","year":"1998","unstructured":"Arias F, Romero R, Joist H, et al.: Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Mater Fetal Med 1998, 7:277\u2013286.","journal-title":"J Mater Fetal Med"},{"key":"26_CR26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM199901073400102","volume":"340","author":"MJ Kupferminc","year":"1999","unstructured":"Kupferminc MJ, Eldor A, Steinman N, et al.: Increased frequency of genetic thrombophilia in women with complications of pregnancy N Engl J Med 1999, 340:9\u201313.","journal-title":"N Engl J Med"},{"key":"26_CR27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/369064a0","volume":"369","author":"R Bertina","year":"1994","unstructured":"Bertina R, Koelman B, Koster T, et al.: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994, 369:64\u201367.","journal-title":"Nature"},{"key":"26_CR28","first-page":"49","volume":"24","author":"J Bonnar","year":"1998","unstructured":"Bonnar J, Green R, Norris L: Inherited thrombophilia and pregnancy: the obstetric perspective. Sem Thromb Hemost 1998, 24:49\u201353.","journal-title":"Sem Thromb Hemost"},{"key":"26_CR29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9378(96)80022-6","volume":"175","author":"DS Dizon-Thownson","year":"1996","unstructured":"Dizon-Thownson DS, Nelson LM, Easton K, et al.: The Factor V Leiden mutation may predispose women to severe preeclampsia. Am J Obstet Gynecol 1996, 175:902\u2013925.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR30","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1055\/s-0038-1656110","volume":"77","author":"E Grandone","year":"1997","unstructured":"Grandone E, Margaglione M, Colaizzo D, et al.: Factor V Leiden, C\u00c6T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost 1997, 77:1052\u20131054.","journal-title":"Thromb Haemost"},{"key":"26_CR31","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0002-9378(98)70025-0","volume":"179","author":"Z Wiener-Megnazi","year":"1998","unstructured":"Wiener-Megnazi Z, Ben-Shlomo I, Goldberg Y, et al.: Resistance to activated protein C and the Leiden mutation: high prevalence in patients with abruptio placentae. Am J Obstet Gynecol 1998, 179:1565\u20131567.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR32","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1055\/s-0038-1656060","volume":"77","author":"E Grandone","year":"1997","unstructured":"Grandone E, Margaglione M, Colaizzo D, et al.: Factor V Leiden is associated with repeated and recurrent fetal loss. Thromb Haemost 1997, 77:822\u2013824.","journal-title":"Thromb Haemost"},{"key":"26_CR33","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00007","volume":"128","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Miletich JP, Buring JE, et al.: Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998, 128:1000\u20131003.","journal-title":"Ann Intern Med"},{"key":"26_CR34","first-page":"349","volume":"81","author":"E Grandone","year":"1990","unstructured":"Grandone E, Margaglione M, Colaizzo D, et al.: Prethrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria. Thromb Haemost 1990, 81:349\u2013352.","journal-title":"Thromb Haemost"},{"key":"26_CR35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jmg.34.6.525","volume":"34","author":"S Sohda","year":"1997","unstructured":"Sohda S, Arinami T, Hamada H, et al.: Methylenetetrahydrofolate reductase polymorphism and preeclampsia. J Med Genet 1997, 34:525\u2013526.","journal-title":"J Med Genet"},{"key":"26_CR36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0301-2115(96)02383-4","volume":"66","author":"TA Goddijn-Wessel","year":"1996","unstructured":"Goddijn-Wessel TA, Wouters MG, van de Molen EF, et al.: Hyperhomocysteinema: a risk factor for placental abruption or infarction. Eur J Obstet Gynecol Reprod Biol 1996, 66:23\u201329.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"26_CR37","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(95)91743-8","volume":"346","author":"NM Put Van der","year":"1995","unstructured":"Van der Put NM, Steegers-Theunissen RP, Frosst P, et al.: Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 1995, 346:1070\u20131071.","journal-title":"Lancet"},{"key":"26_CR38","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0002-9378(98)70033-X","volume":"179","author":"RW Powers","year":"1998","unstructured":"Powers RW, Evans RW, Majors AK, et al.: Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998, 179:1605\u20131611.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR39","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0029-7844(98)00527-4","volume":"93","author":"H Laivuori","year":"1999","unstructured":"Laivuori H, Kaaja R, Turpeinen U, et al.: Plasma homocysteine levels elevated and inversely related to insulin sensitivity in preeclampsia. Obstet Gynecol 1999, 93:489\u2013493.","journal-title":"Obstet Gynecol"},{"key":"26_CR40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9378(98)70263-7","volume":"170","author":"M Leeda","year":"1998","unstructured":"Leeda M, Rijozi N, de Vries JIP, et al.: Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 1998, 170:135\u2013139.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR41","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0029-7844(97)00713-8","volume":"91","author":"SR Kahn","year":"1998","unstructured":"Kahn SR: Severe preeclampsia associated with coinheritance of Factor V Leiden mutation and protein S deficiency. Obstet Gynecol 1998, 91:812\u2013814.","journal-title":"Obstet Gynecol"},{"key":"26_CR42","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1471-0528.1997.tb10970.x","volume":"104","author":"JI Vries De","year":"1997","unstructured":"De Vries JI, Dekker GA, Huijgens PC, et al.: Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol 1997, 104:1248\u20131254.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR43","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1177\/096120339800700221","volume":"7","author":"S Cowchock","year":"1998","unstructured":"Cowchock S: Treatment of antiphospholipid syndrome in pregnancy Lupus 1998, 7:S95-S97.","journal-title":"Lupus"},{"key":"26_CR44","first-page":"907","volume":"157","author":"JM Moutquin","year":"1997","unstructured":"Moutquin JM, Garner PR, Burrows RF, et al.: Report of the Canadian Hypetension Society Consensus Conference 2: nonpharmacologic management and prevention of hypertensive disorders in pregnancy. Can Med Assoc J 1997, 157:907\u2013919.","journal-title":"Can Med Assoc J"},{"key":"26_CR45","first-page":"1245","volume":"157","author":"E Rey","year":"1997","unstructured":"Rey E, Le Lorier J, Burgess E, et al.: Report of the Canadian Hypertensive Society Consensus Conference 3: pharmacologic treatment of hypertension disorders in pregnancy Can Med Assoc J 1997, 157:1245\u20131254.","journal-title":"Can Med Assoc J"},{"key":"26_CR46","first-page":"829","volume":"149","author":"M Helewa","year":"1993","unstructured":"Helewa M, Heaman M, Robinson MA, et al.: Community-based home care program for the management of preeclampsia: an alternative Can Med Assoc J 1993, 149:829\u2013834.","journal-title":"Can Med Assoc J"},{"key":"26_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-536X.1995.tb00546.x","volume":"22","author":"LE Josten","year":"1996","unstructured":"Josten LE, Savik K, Mullet SE, et al.: Bed rest compliance for women with pregnancy problems. Birth 1996, 22:1\u201312.","journal-title":"Birth"},{"key":"26_CR48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1471-0528.1992.tb14384.x","volume":"99","author":"CA Crowther","year":"1992","unstructured":"Crowther CA, Bouwmeester AM, Ashurst HM: Does admission to hospital for bed rest prevent progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension? Br J Obstet Gynaecol 1992, 99:13\u201318.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR49","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0029-7844(95)00006-D","volume":"85","author":"FY Chan","year":"1995","unstructured":"Chan FY, Pun TC, Lam C, et al.: Pregnancy screening by uterine artery Doppler velocimetry: which criterion performs best? Obstet Gynecol 1995, 85:596\u2013602.","journal-title":"Obstet Gynecol"},{"key":"26_CR50","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0002-9378(98)70154-1","volume":"179","author":"GJ Mires","year":"1998","unstructured":"Mires GJ, Williams FLR, Leslie J, et al.: Assessment of uterine arterial notching as a screening test for adverse pregnancy outcome. Am J Obstet Gynecol 1998, 179:1317\u20131323.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR51","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1034\/j.1600-0412.1998.770607.x","volume":"77","author":"K Asselt Van","year":"1998","unstructured":"Van Asselt K, Gudmundsson S, Lindqvist P, et al.: Uterine and umbilical artery velocimetry in pre-eclampsia. Acta Obstet Gynecol Scand 1998, 77:614\u2013619.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"26_CR52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/j.1600-0412.1998.770510.x","volume":"77","author":"KG Wang","year":"1998","unstructured":"Wang KG, Chen CP, Yang JM, et al.: Impact of reverse enddiastolic flow velocity in umbilical artery on pregnancy outcome after the 28th gestational week. Acta Obstet Gynecol Scand 1998, 77:527\u2013531.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"26_CR53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-9378(94)70240-3","volume":"170","author":"AMWJ Omtzigt","year":"1994","unstructured":"Omtzigt AMWJ, Reuwer PJHM, Bruinse HW: A randomized controlled trial on the clinical value of umbilical Doppler velocimetry in antenatal care. Am J Obstet Gynecol 1994, 170:625\u2013634.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR54","first-page":"2","volume-title":"Cochrane Collaborations: Cochrane Database of Systematic Reviews: Pregnancy and Childbirth Module","author":"JP Nielson","year":"1999","unstructured":"Nielson JP, Alfirevic Z: Doppler ultrasound for fetal assessment in high-risk pregnancies. In Cochrane Collaborations: Cochrane Database of Systematic Reviews: Pregnancy and Childbirth Module. Oxford:Update Software; 1999, 2."},{"key":"26_CR55","volume-title":"Cochrane Collaborations: Cochrane Database of Systematic Reviews: Pregnancy and Childbirth Module","author":"R Collins","year":"1995","unstructured":"Collins R, Duley L: Any antihypertensive therapy for pregnancy hypertension. In Cochrane Collaborations: Cochrane Database of Systematic Reviews: Pregnancy and Childbirth Module. Oxford:Update Software; 1995."},{"key":"26_CR56","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1136\/bmj.318.7194.1332","volume":"318","author":"LA Magee","year":"1999","unstructured":"Magee LA, Ornstein MP, von Dadelszen P: Fortnightly review: management of hypertension in pregnancy. BMJ 1999, 318:1332\u20131336. The most recent meta-analysis on various subjects related to hypertension in pregnancy.","journal-title":"BMJ"},{"key":"26_CR57","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(97)06408-8","volume":"350","author":"DW Steyn","year":"1997","unstructured":"Steyn DW, Odendaal HJ: Randomised controlled trial of ketanserin and aspirin in prevention of pre-eclampsia. Lancet 1997, 350:1267\u20131271.","journal-title":"Lancet"},{"key":"26_CR58","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1471-0528.1998.tb10201.x","volume":"105","author":"Gruppo di Studio Ipertensione in Gravidanza","year":"1998","unstructured":"Gruppo di Studio Ipertensione in Gravidanza: Nifedipine versus expectant management in mild to moderate hypertension in pregnancy Br J Obstet Gynaecol 1998, 105:718\u2013722.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR59","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000010080","volume":"47","author":"P Tamas","year":"1999","unstructured":"Tamas P, Csermely T, Ertl T, et al.: Calcium dobesilate lowers the blood pressure in mild to moderate midtrimester hypertension: a pilot study. Gynecol Obstet Invest 1999, 47:210\u2013213.","journal-title":"Gynecol Obstet Invest"},{"key":"26_CR60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","volume":"343","author":"CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group","year":"1994","unstructured":"CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group: A randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994, 343:619\u2013629.","journal-title":"Lancet"},{"key":"26_CR61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","volume":"105","author":"J Golding","year":"1998","unstructured":"Golding J, on behalf of the Jamaica Low-Dose Aspirin Study Group: A randomized trial of low-dose aspirin for primiparae in pregnancy Br J Obstet Gynaecol 1998, 105:293\u2013299.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR62","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","volume":"105","author":"YE Rotchell","year":"1998","unstructured":"Rotchell YE, Cruickshank JK, Phillips GM, et al.: Barbados Low-Dose Aspirin in Pregnancy (BLASP): a randomized trial for the prevention of preeclampsia and its complications. Br J Obstet Gynaecol 1998, 105:286\u2013292.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1471-0528.1996.tb09513.x","volume":"103","author":"ECPPA (Estudo Collaborative Para Prevencao da Pre-eclampsia com Aspirina) Collaborative Group","year":"1996","unstructured":"ECPPA (Estudo Collaborative Para Prevencao da Pre-eclampsia com Aspirina) Collaborative Group: Randomised trial of low-dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obstet Gynaecol 1996, 103:39\u201347.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR64","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","volume":"338","author":"SN Caritis","year":"1998","unstructured":"Caritis SN, Sibai BM, Hauth J, et al.: Low-dose aspirin therapy for the prevention of preeclampsia in high-risk women. N Engl J Med 1998, 338:701\u2013705.","journal-title":"N Engl J Med"},{"key":"26_CR65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9378(99)70163-8","volume":"180","author":"A Dumont","year":"1999","unstructured":"Dumont A, Flahault A, Beaufils M, et al.: Effect of aspirin in pregnant women is dependent on increase in bleeding time. Am J Obstet Gynecol 1999, 180:135\u2013140.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR66","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1471-0528.1996.tb09829.x","volume":"103","author":"SJ Bower","year":"1996","unstructured":"Bower SJ, Harrington KF, Schuchter K, et al.: Prediction of preeclampsia by abnormal uterine Doppler ultrasound and modification by aspirin. Br J Obstet Gynaecol 1996, 103:625\u2013629.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR67","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1056\/NEJM199111143252002","volume":"325","author":"JM Belizan","year":"1991","unstructured":"Belizan JM, Villar J, Gonzalez L, et al.: Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991, 325:1399\u20131405.","journal-title":"N Engl J Med"},{"key":"26_CR68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199707103370201","volume":"337","author":"RJ Levine","year":"1997","unstructured":"Levine RJ, Hauth JC, Curet LB, et al.: Trial of calcium to prevent preeclampsia. N Engl J Med 1997, 337:69\u201376.","journal-title":"N Engl J Med"},{"key":"26_CR69","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0002-9378(88)80072-3","volume":"159","author":"GD Waisman","year":"1988","unstructured":"Waisman GD, Mayorgoi LM, Camera MI, et al.: Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia? Am J Obstet Gynecol 1988, 159:308\u2013309.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR70","first-page":"3","volume-title":"Cochrane Collaborations: Cochrane Database of Systematic Reviews: Pregnancy and Childbirth Module","author":"Henderson-Smart DJ Duley L","year":"1999","unstructured":"Duley L, Henderson-Smart DJ: Drugs for rapid treatment of very high blood pressure during pregnancy. In Cochrane Collaborations: Cochrane Database of Systematic Reviews: Pregnancy and Childbirth Module. Oxford:Update Software; 1999, 3."},{"key":"26_CR71","first-page":"328","volume":"70","author":"WC Mabie","year":"1987","unstructured":"Mabie WC, Gonzalez AR, Sibai SM, et al.: A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987, 70:328\u2013333.","journal-title":"Obstet Gynecol"},{"key":"26_CR72","first-page":"25","volume":"11","author":"S Matins-Costa","year":"1992","unstructured":"Matins-Costa S, Ramos JG, Barros E, et al.: Randomized, controlled trial of hydralazine versus nifedipine in preeclamptic women with acute hypertension. Clin Exp Hypertens 1992, 11:25\u201344.","journal-title":"Clin Exp Hypertens"},{"key":"26_CR73","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0002-9378(99)70216-4","volume":"80","author":"AC Bolte","year":"1999","unstructured":"Bolte AC, van Eyck J, Kanhai HH, et al.: Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome. Am J Obstet Gynecol 1999, 80(pt 1):371\u2013377.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR74","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/oxfordjournals.ndt.a027825","volume":"13","author":"J Wacker","year":"1998","unstructured":"Wacker J, Werner P, Walter-Sack I, et al.: Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing digydralazine with urapidil. Nephrol Dial Transplant 1998, 13:318\u2013325.","journal-title":"Nephrol Dial Transplant"},{"key":"26_CR75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF03009631","volume":"40","author":"N Kumar","year":"1993","unstructured":"Kumar N, Batra YK, Bala I, et al.: Nifedipine attenuates the hypertensive response to tracheal intubation in pregnancyinduced hypertension. Can J Anaesth 1993, 40:329\u2013333.","journal-title":"Can J Anaesth"},{"key":"26_CR76","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0002-9378(88)80027-9","volume":"159","author":"J Ramanathan","year":"1988","unstructured":"Ramanathan J, Sibai BM, Mabie WC, et al.: The use of labetalol for attenuation of the hypertensive response to endotracheal intubation in preeclampsia. Am J Obstet Gynecol 1988, 159:650\u2013654.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR77","first-page":"772","volume":"73","author":"J Ramanathan","year":"1991","unstructured":"Ramanathan J, Coleman P, Sibai BM: Anesthetic modification of hemodynamic and neuroendocrine stress responses to cesarean delivery in women with severe preeclampsia. Anesth Analg 1991, 73:772\u2013779.","journal-title":"Anesth Analg"},{"key":"26_CR78","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0140-6736(95)91034-4","volume":"345","author":"The Eclampsia Trial Collaborative Group","year":"1995","unstructured":"The Eclampsia Trial Collaborative Group: Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995, 345:1455\u20131463.","journal-title":"Lancet"},{"key":"26_CR79","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1471-0528.1998.tb10090.x","volume":"105","author":"EJ Coetzee","year":"1998","unstructured":"Coetzee EJ, Dommisse J, Anthony J: A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 1998, 105:300\u2013303.","journal-title":"Br J Obstet Gynaecol"},{"key":"26_CR80","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJM199507273330401","volume":"333","author":"MJ Lucas","year":"1995","unstructured":"Lucas MJ, Leveno KJ, Cunningham FG: A comparison of magnesium sulfate with phenytoin for the prevention of preeclampsia. N Engl J Med 1995, 333:201\u2013205.","journal-title":"N Engl J Med"},{"key":"26_CR81","first-page":"2","volume-title":"Cochrane Collaborations: Cochrane Database of Systematic Reviews: Pregnancy and Childbirth Module","author":"L Duley","year":"1999","unstructured":"Duley L, Gulmezoglu AM, Henderso-Smart DJ: Anticonvulsants for preeclampsia. In Cochrane Collaborations: Cochrane Database of Systematic Reviews: Pregnancy and Childbirth Module. Oxford:Update Software; 1999, 2."},{"key":"26_CR82","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0002-9378(95)90368-2","volume":"173","author":"RF Burrows","year":"1995","unstructured":"Burrows RF, Burrows EA: The feasibility of a control population for a randomized control trial of seizure prophylaxis in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1995, 173:929\u2013935.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR83","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0002-9378(88)90003-8","volume":"158","author":"SL Clark","year":"1988","unstructured":"Clark SL, Cotton DB: Clinical indications for pulmonary artery catheterization in the patient with severe preeclampsia. Am J Obstet Gynecol 1988, 158:453\u2013458.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR84","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/0002-9378(86)90588-0","volume":"154","author":"SL Clark","year":"1986","unstructured":"Clark SL, Greenspoon JS, Aldahl D, et al.: Severe preeclampsia with persistant oliguria: management of hemodynamic subsets. Am J Obstet Gynecol 1986, 154:490\u2013494.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR85","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0002-9378(85)80222-2","volume":"152","author":"TJ Benedetti","year":"1985","unstructured":"Benedetti TJ, Kates R, Williams V: Hemodynamic observations in severe preeclampsia complicated by pulmonary edema. Am J Obstet Gynecol 1985, 152:330\u2013334.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR86","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/0002-9378(93)90417-H","volume":"169","author":"MA Belfort","year":"1993","unstructured":"Belfort MA, Anthony J, Saade GR, et al.: The oxygen consumption\/oxygen delivery curve in severe preeclampsia: evidence for a fixed oxygen extraction state. Am J Obstet Gynecol 1993, 169:1448\u20131455.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR87","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199406163302404","volume":"330","author":"MA Hayes","year":"1994","unstructured":"Hayes MA, Timmins AC, Yau EHS, et al.: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330:1717\u20131722.","journal-title":"N Engl J Med"},{"key":"26_CR88","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJM199510193331601","volume":"333","author":"L Gattinoni","year":"1995","unstructured":"Gattinoni L, Brazzi L, Pelosi P, et al.: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995, 333:1025\u20131032.","journal-title":"N Engl J Med"},{"key":"26_CR89","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/0002-9378(94)90104-X","volume":"171","author":"BM Sibai","year":"1994","unstructured":"Sibai BM, Mercer BM, Schiff E, et al.: Aggressive versus conservative management of severe preeclampsia at 28 to 32 weeks\u2019 gestation: a randomized controlled trial. Am J Obstet Gynecol 1994, 171:818\u2013822.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR90","first-page":"1070","volume":"76","author":"HJ Odendaal","year":"1990","unstructured":"Odendaal HJ, Pattinson RC, Bam R, et al.: Aggressive or expectant management for patients with severe preeclampsia between 28\u2013-34 weeks\u2019 gestation: a randomized controlled trial. Obstet Gynecol 1990, 76:1070\u20131075.","journal-title":"Obstet Gynecol"},{"key":"26_CR91","first-page":"331","volume":"77","author":"K Fenakel","year":"1991","unstructured":"Fenakel K, Fenakel G, Appelman Z, et al.: Nifedipine in the treatment of severe preeclampsia. Obstet Gynecol 1991, 77:331\u2013337.","journal-title":"Obstet Gynecol"},{"key":"26_CR92","first-page":"626","volume":"84","author":"E Schiff","year":"1994","unstructured":"Schiff E, Friedman SA, Sibai BM: Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994, 84:626\u2013630.","journal-title":"Obstet Gynecol"},{"key":"26_CR93","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0002-9378(96)70047-9","volume":"175","author":"E Schiff","year":"1996","unstructured":"Schiff E, Friedman SA, Kao L, et al.: The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol 1996, 175:1313\u20131316.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR94","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0002-9378(76)90168-X","volume":"124","author":"SC Chesley","year":"1976","unstructured":"Chesley SC, Annitto JE, Cosgrove RA: The remote prognosis of eclamptic women: sixth periodic report. Am J Obstet Gynecol 1976, 124:446\u2013459.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR95","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/0002-9378(92)91566-S","volume":"166","author":"BM Sibai","year":"1992","unstructured":"Sibai BM, Sarinoglu C, Mercer BM: Eclampsia VII: pregnancy outcome after eclampsia and long-term prognosis. Am J Obstet Gynecol 1992, 166:1757\u20131763.","journal-title":"Am J Obstet Gynecol"},{"key":"26_CR96","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3109\/00016349509021195","volume":"74","author":"LS Jonsdottir","year":"1995","unstructured":"Jonsdottir LS, Arngrimsson R, Geirsson RT, et al.: Death rates from ischemic heart disease in women with a history of hypertension in pregnancy Acta Obstet Gynecol Scand 1995, 74:772\u2013776.","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-996-0026-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-996-0026-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-996-0026-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:14:44Z","timestamp":1559434484000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-996-0026-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,12]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,12]]}},"alternative-id":["26"],"URL":"https:\/\/doi.org\/10.1007\/s11906-996-0026-7","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,12]]}}}